HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yawei Yuan Selected Research
Yawei Yuan Research Topics
Disease
28
Neoplasms (Cancer)
01/2022 - 10/2003
11
Nasopharyngeal Carcinoma
03/2022 - 10/2013
8
Breast Neoplasms (Breast Cancer)
01/2021 - 04/2012
7
Neoplasm Metastasis (Metastasis)
03/2022 - 02/2015
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 12/2017
4
Brain Neoplasms (Brain Tumor)
01/2020 - 07/2017
4
Lung Neoplasms (Lung Cancer)
01/2020 - 07/2012
3
Glioma (Gliomas)
01/2022 - 11/2016
3
Carcinogenesis
10/2021 - 11/2016
3
Carcinoma (Carcinomatosis)
01/2021 - 10/2003
3
Squamous Cell Carcinoma of Head and Neck
11/2020 - 01/2018
3
Hypoxia (Hypoxemia)
12/2018 - 07/2015
2
Cognitive Dysfunction
06/2022 - 01/2022
2
Inflammation (Inflammations)
06/2022 - 10/2020
2
Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2018
2
Esophageal Squamous Cell Carcinoma
03/2020 - 01/2019
2
Stomach Neoplasms (Stomach Cancer)
05/2019 - 01/2013
1
Disease Progression
03/2022
1
Adenocarcinoma
01/2021
1
COVID-19
01/2021
1
Neuroendocrine Carcinoma
01/2021
1
Urologic Neoplasms (Urological Cancer)
01/2021
1
Fibrosis (Cirrhosis)
01/2019
1
Pneumonia (Pneumonitis)
01/2019
1
Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2019
1
Glioblastoma (Glioblastoma Multiforme)
12/2018
Drug/Important Bio-Agent (IBA)
9
Proteins (Proteins, Gene)
FDA Link
01/2022 - 10/2003
6
Messenger RNA (mRNA)
IBA
01/2022 - 03/2012
6
Biomarkers (Surrogate Marker)
IBA
01/2022 - 10/2003
5
Small Interfering RNA (siRNA)
IBA
12/2021 - 01/2016
5
MicroRNAs (MicroRNA)
IBA
01/2021 - 07/2012
3
Pharmaceutical Preparations
IBA
01/2022 - 01/2021
3
Biological Products
IBA
01/2022 - 10/2003
3
Cytokines
IBA
11/2020 - 04/2012
2
Isoflurane
FDA Link
Generic
06/2022 - 01/2022
2
Indicators and Reagents (Reagents)
IBA
03/2022 - 01/2022
2
Anaplastic Lymphoma Kinase
IBA
01/2022 - 08/2015
2
Vimentin
IBA
01/2021 - 08/2015
2
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
01/2021 - 01/2017
2
RNA (Ribonucleic Acid)
IBA
01/2021 - 11/2020
2
Nucleotides
IBA
01/2021 - 11/2020
2
Angiotensinogen
IBA
01/2021 - 12/2018
2
Long Noncoding RNA
IBA
10/2019 - 11/2016
2
Angiotensin II
IBA
12/2018 - 01/2017
2
Lactic Acid (Lactate)
FDA Link
Generic
12/2018 - 01/2017
2
Chymases (Chymase)
IBA
12/2018 - 01/2017
2
ErbB Receptors (EGF Receptor)
IBA
08/2018 - 01/2018
1
Superoxide Dismutase
IBA
03/2022
1
Phosphoproteins
IBA
01/2022
1
apatinib
IBA
12/2021
1
cyclic arginine-glycine-aspartic acid peptide
IBA
12/2021
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
12/2021
1
Hormones (Hormone)
IBA
10/2021
1
Melatonin
IBA
10/2021
1
Capsules (Microcapsules)
IBA
09/2021
1
Synaptophysin
IBA
01/2021
1
GSK 461364
IBA
01/2021
1
Angiotensin Receptors (Angiotensin II Receptor)
IBA
01/2021
1
3-nitrophenyl 3-piperidinecarboxylate (MNPC)
IBA
01/2021
1
TOR Serine-Threonine Kinases
IBA
01/2021
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2021
1
Serine Proteases (Serine Protease)
IBA
01/2021
1
Carcinoembryonic Antigen
IBA
01/2021
1
Chromogranin A
IBA
01/2021
1
Polo-Like Kinase 1
IBA
01/2021
1
histidine-rich proteins
IBA
01/2021
1
Angiotensin-Converting Enzyme 2
IBA
01/2021
1
Lysine (L-Lysine)
FDA Link
01/2021
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2021
1
Protein Kinases (Protein Kinase)
IBA
01/2021
1
Mitogen-Activated Protein Kinases
IBA
10/2020
1
NF-kappa B (NF-kB)
IBA
10/2020
1
benzamidine
IBA
03/2020
1
alvocidib (flavopiridol)
IBA
03/2020
1
Zinc
IBA
03/2020
1
4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamide
IBA
03/2020
1
Glutamine (L-Glutamine)
FDA Link
03/2020
1
nelarabine (506U78)
FDA Link
03/2020
1
1- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)urea
IBA
03/2020
1
Fluorouracil (Carac)
FDA Link
Generic
03/2020
1
taxane
IBA
03/2020
1
Cisplatin (Platino)
FDA Link
Generic
01/2020
1
Ubiquitin-Specific Proteases
IBA
01/2020
1
DNA (Deoxyribonucleic Acid)
IBA
01/2020
1
Tyrosine Kinase Inhibitors
IBA
01/2019
1
Sincalide
FDA Link
01/2019
1
Small Cytoplasmic RNA
IBA
01/2019
1
N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamide
IBA
01/2019
1
Polygeline
IBA
12/2018
1
Immune Checkpoint Inhibitors
IBA
08/2018
Therapy/Procedure
16
Radiotherapy
01/2021 - 10/2013
9
Therapeutics
04/2022 - 11/2016
5
Drug Therapy (Chemotherapy)
01/2020 - 04/2014
4
Chemoradiotherapy
01/2022 - 02/2015
2
Immunotherapy
11/2020 - 12/2018
2
Gastrectomy
05/2019 - 01/2013
1
Anesthesia
06/2022
1
Aftercare (After-Treatment)
01/2021
1
Surgical Instruments (Clip)
01/2021
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020